Cargando…
Ibrutinib modulates Aβ/tau pathology, neuroinflammation, and cognitive function in mouse models of Alzheimer's disease
We previously demonstrated that ibrutinib modulates LPS‐induced neuroinflammation in vitro and in vivo, but its effects on the pathology of Alzheimer's disease (AD) and cognitive function have not been investigated. Here, we investigated the effects of ibrutinib in two mouse models of AD. In 5x...
Autores principales: | Lee, Hyun‐ju, Jeon, Seong Gak, Kim, Jieun, Kang, Ri Jin, Kim, Seong‐Min, Han, Kyung‐Min, Park, HyunHee, Kim, Ki‐taek, Sung, You Me, Nam, Hye Yeon, Koh, Young Ho, Song, Minseok, Suk, Kyoungho, Hoe, Hyang‐Sook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963331/ https://www.ncbi.nlm.nih.gov/pubmed/33709472 http://dx.doi.org/10.1111/acel.13332 |
Ejemplares similares
-
Regorafenib Regulates AD Pathology, Neuroinflammation, and Dendritic Spinogenesis in Cells and a Mouse Model of AD
por: Han, Kyung-Min, et al.
Publicado: (2020) -
L-Type Ca(2+) Channel Inhibition Rescues the LPS-Induced Neuroinflammatory Response and Impairments in Spatial Memory and Dendritic Spine Formation
por: Kim, Jieun, et al.
Publicado: (2022) -
The VEGF inhibitor vatalanib regulates AD pathology in 5xFAD mice
por: Jeon, Seong Gak, et al.
Publicado: (2020) -
Repurposing ibrutinib: therapeutic effects and implications for translational approaches in Alzheimer’s disease
por: Lee, Hyun-ju, et al.
Publicado: (2023) -
The MAO Inhibitor Tranylcypromine Alters LPS- and Aβ-Mediated Neuroinflammatory Responses in Wild-type Mice and a Mouse Model of AD
por: Park, HyunHee, et al.
Publicado: (2020)